Personalizing Precision Oncology: From Light Microscope to Molecular Microscope

Restricted access
  • 1.

    Subbiah V, Kurzrock R. Challenging standard-of-care paradigms in the precision oncology era. Trends Cancer 2018;4:101109.

  • 2.

    Tsai KK, Khurana N, McCalmont T, PTCH1 mutation in a patient with metastatic undifferentiated carcinoma with clear cell change. J Natl Compr Canc Netw 2019;17:778–783.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Groisberg R, Hong DS, Roszik J, Clinical next-generation sequencing for precision oncology in rare cancers. Mol Cancer Ther 2018;17:15951601.

  • 4.

    Groisberg R, Hong DS, Holla V, Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget 2017;8:3925439267.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Campbell BB, Light N, Fabrizio D, Comprehensive analysis of hypermutation in human cancer. Cell 2017;171:10421056.e1010.

  • 6.

    Patel SP, Kurzrock R. PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther 2015;14:847856.

  • 7.

    Kato S, Subbiah V, Kurzrock R. Counterpoint: successes in the pursuit of precision medicine: biomarkers take credit. J Natl Compr Canc Netw 2017;15:863866.

  • 8.

    Marcus L, Lemery SJ, Keegan P, Pazdur R. FDA approval summary: pembrolizumab for the treatment of microsatellite instability-high solid tumors [published online February 20, 2019]. Clin Cancer Res, doi: 10.1158/1078-0432.CCR18-4070

    • Search Google Scholar
    • Export Citation
  • 9.

    Boyiadzis MM, Kirkwood JM, Marshall JL, Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease. J Immunother Cancer 2018;6:35.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Subbiah V, Kurzrock R. The marriage between genomics and immunotherapy: mismatch meets its match. Oncologist 2019;24:13.

  • 11.

    Singh RR, Murugan P, Patel LR, Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy. Mod Pathol 2015;28:12251235.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 1636 1089 289
PDF Downloads 436 306 40
EPUB Downloads 0 0 0